Renowned Speakers

Brain Disorders Conferences, Brain Disorders 2025, Neurology Conferences, Neuroscience Conferences, Neurobiology Meetings, Neurological Disorders Summit Europe, Brain and Neurology Disorders Conference, Dementia Conferences Asia, Psychiatry Conferences, Mental Disorders Conferences, Mental Health Conferences

Shireen-Qureshi

Saudi Stroke Association Saudi Arabia

Peter-Silburn

The University of Queensland Australia

Christianto-B-Lumenta

University of Munich Germany

Walter-E-Muller

University of Frankfurt Germany

Masako-Okawa

Tokyo Medical University Japan

Olivier-Dapremont

AMPAC Fine Chemicals LLC USA

Bo-Feng

University of Hong Kong Hong Kong

Katie-Lawton

North West Deanery UK

Recommended Global Neuroscience Webinars & Conferences

Europe & UK

ACMH-2026, France Aging 2025, Spain Agriculture 2025, France Agri 2025, Italy

Asia Pacific & Middle East

Big Data 2025, UAE CROPS-AGRI-2025, Indonesia Heart 2025, Japan PCOS 2025, UAE

Canada

CAM 2025, Canada Cell Signaling 2025, Canada Clinical Cardiology 2025, Canada Pharmatech 2025, Canada

Brain Disorders-2025

About Conference

First Round of Abstract Submission Deadline

28^th June 2025

We extends a warm invitation to participants worldwide to join us at the 14^th International Conference on Brain Disorders and Therapeutics. The aim of the Brain Disorders Congress is to bring together globally recognized scholars in neuroscience and neurology, neurospecialists, public health experts, clinicians, academic researchers, industry analysts, and scientists to discuss cutting-edge research and advancements. Brain Disorders 2025 aims to recognize and honor talented young researchers, scientists, post-graduate students, post-doctoral fellows, trainees, and junior faculty for their outstanding contributions to the conference theme through prestigious awards. The Young Scientist Awards provide a platform for early career academicians to engage with experts, exchange experiences, and enhance professional development in the field of Neurology.

Why to Attend????

Brain Disorders 2025 offers numerous benefits that contribute to both professional and personal growth. One of the most significant advantages is the opportunity to network with researchers, scholars, and industry professionals from around the world. These interactions can lead to future collaborations, mentorship, and even career opportunities. Brain Disorders 2025 provide a platform to stay updated with the latest research, trends, and technological advancements in your field. Presenting your research—whether through oral or poster sessions—enhances your communication skills and provides valuable feedback from peers and experts. Such feedback can help refine your work and inspire new ideas. Exposure to diverse viewpoints through panel discussions and interdisciplinary sessions broadens your knowledge and stimulates critical thinking. For early-career researchers, Brain Disorders 2025 offer a chance to build their academic profile, gain recognition, and explore funding and publication opportunities. Participation often includes earning certificates and CPD/CME credits, which are valuable for professional development and licensing. Brain Disorders 2025 feature technology demonstrations and vendor exhibits, showcasing the latest tools and innovations relevant to your field. Engaging in these events fosters a deeper understanding of practical applications and research methodologies.
Beyond academics, Brain Disorders 2025 contribute to personal development. They boost confidence, improve time management, and enhance public speaking and interpersonal communication skills. The dynamic environment often reignites enthusiasm for research and fosters a sense of belonging within the academic community.

Benefits Brain Disorders 2025 Conference:

Accepted abstracts will be published in Scopus/Pubmed Journals with DOI
Global networking: In exchanging and trading Ideas
A Unique Opportunity for Advertisers and Sponsors at this International meeting
Learn about the latest research in your field
Young Researcher Awards for new researchers
Obtain feedback on your research
Meet and get to know your peers
An attendance certificate from the members of the organizing committee.
Get CME/CPD Credits
Gain visibility in your field
Share your research findings with others in your field
Stay on top of trends and topics
Promote Creativity & Innovation in business field

Target Audience:

Neurologists, Brain Researchers, Doctors, Psychologist, Business Delegates, Neuro-oncologists, Industrial Leaders, CEOs, R&D Heads from Industries, Directors, Neuro-radiologists, Neurosurgeons, Psychiatrists, Department Heads, Brain Coaches, Physicians, Professors, and Students from Academic Institutions involved in brain disorders and neurology research.

Scientific Tracks

Track 1: Brain Disorders

Brain is the most complex and sensitive organ in the body. Minute damages to the brain might cause devastating consequences leading to several brain disorders. It may occur in early childhood causing developmental disorders such as autism and dyslexia .Psychiatric diseases such as depression and schizophrenia are typically diagnosed in teens or early adulthood and as we age we become increasingly susceptible to Alzheimer’s disease, Parkinson’s disease, stroke, and other diseases. This session encourages a discussion on the structural and functional aspects of the brain. There are 10 million individuals in the UK living with a neurological condition which significantly affects their lives. Basically, stroke, dementia, cerebral pain, Brain damage and epilepsy are the neurological conditions endured in the UK. It has been evaluated that the lifetime danger of developing Brain and other neural sensory system disease is 1 of every 133 for men and 1 of every 185 for ladies in the UK.

Track 2: Brain Cancer & Tumors

Brain cancer is a disease of the brain in which cancer cells (malignant cells) arise in the brain tissue (cancer of the brain). Cancer cells grow to form a mass of cancer tissue (tumor) that interferes with brain functions such as muscle control, sensation, memory, and other normal body functions. Tumors composed of cancer cells are called malignant tumors, and those composed of mainly noncancerous cells are called benign tumors. Cancer cells that develop from brain tissue are called primary brain tumors while tumors that spread from other body sites to the brain are termed metastatic or secondary brain tumors. Only about 5% of brain tumors may be due to hereditary genetic conditions such as neurofibromatosis, tuberous sclerosis, and a few others.

Track 3: Neurological Disorders

Any disorder happen at the body nervous system is called as Neurological Disorders. Abnormalities in the brain, spinal cord or other nerves like Structural, biochemical or electrical can result as symptoms sometime. Neurological disorder symptoms might be loss of sensation, Poor Coordination, muscle weakness, paralysis, confusion, pain and altered levels of consciousness. Causes for the neurological disorder can be biochemical changes and sometimes can be physical injury to the brain, spinal cord, or nerves. But in some case the root cause can’t be determined only effects are seen.

Track 4: Neuroimmunology

Neuroimmunology is a field combining neuroscience, the study of the nervous system, and immunology, the study of the immune system. Neuroimmunologists seek to better understand the interactions of these two complex systems during development, homeostasis, and response to injuries. A long-term goal of this rapidly developing research area is to further develop our understanding of the pathology of certain neurological diseases, some of which have no clear etiology. Neuroimmunology contributes to development of new pharmacological treatments for several neurological conditions. Many types of interactions involve both the nervous and immune systems including the physiological functioning of the two systems in health and disease, malfunction of either and or both systems that leads to disorders, and the physical, chemical, and environmental stressors that affect the two systems on a daily basis

Track 5: Neurodiversity in Clinical Practice

Neurodiversity in clinical practice recognizes and respects the natural variations in brain function and behavior among individuals, including those with autism, ADHD, dyslexia, and other cognitive differences. Rather than viewing these conditions solely as deficits or disorders, the neurodiversity perspective emphasizes strengths, alternative ways of thinking, and the value of diverse cognitive profiles. In clinical settings, this approach encourages personalized care that is responsive to each individual’s unique needs, communication style, and sensory preferences. It promotes inclusive diagnostic assessments, strength-based interventions, and collaborative decision-making that empower patients. Neurodiversity-informed practice also challenges stigma and supports accommodations in education, work, and healthcare environments. Clinicians are increasingly being trained to move beyond a pathology-based model, fostering acceptance and understanding. Integrating neurodiversity into clinical practice not only improves therapeutic relationships and outcomes but also contributes to a more compassionate and inclusive healthcare system that affirms the dignity and identity of neurodivergent individuals.

Track 6: Artificial Intelligence in Neurology

Artificial Intelligence (AI) is transforming neurology by enhancing diagnostic accuracy, treatment planning, and research capabilities. Using machine learning algorithms and deep neural networks, AI can analyze complex neurological data such as brain scans, EEGs, and genetic profiles with remarkable precision. This helps in early detection of conditions like Alzheimer’s, Parkinson’s, epilepsy, and multiple sclerosis, often before clinical symptoms appear. AI also supports personalized medicine by predicting disease progression and treatment responses based on patient-specific data. In stroke care, AI can rapidly interpret imaging to guide emergency interventions. Moreover, AI-powered tools are improving neurorehabilitation through adaptive therapies and brain-computer interfaces. Despite these advances, challenges remain, including data privacy, interpretability of AI decisions, and the need for large, diverse datasets. As technology evolves, collaboration between neurologists, data scientists, and ethicists is essential to ensure that AI is safely and effectively integrated into clinical neurology, ultimately improving patient outcomes and healthcare delivery.

Track 7: Aging and Cognitive Decline

Aging and cognitive decline are natural processes that affect many individuals as they grow older. While some degree of memory loss and slower processing speeds are common with age, more significant cognitive impairments can signal conditions like mild cognitive impairment (MCI) or dementia, including Alzheimer’s disease. Age-related cognitive decline is influenced by genetic, lifestyle, and environmental factors, with vascular health, nutrition, physical activity, and mental stimulation playing key roles. The brain undergoes structural and functional changes with age, such as shrinkage in certain regions, reduced neurotransmitter levels, and decreased synaptic plasticity. Early detection through cognitive assessments and neuroimaging is crucial for managing symptoms and slowing progression. Interventions like cognitive training, physical exercise, social engagement, and medications may help preserve function and improve quality of life. As life expectancy increases globally, understanding and addressing cognitive decline is a growing priority in healthcare and neuroscience research to support healthy aging.

Track 8: Neuroinflammation and Neurodegeneration

Neuroinflammation and neurodegeneration are closely linked processes involved in many neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis (ALS). Neuroinflammation refers to the activation of the brain’s immune cells—primarily microglia and astrocytes—in response to injury, infection, or disease. While this response is protective in the short term, chronic inflammation can become harmful, contributing to neuronal damage and death. This persistent immune activity releases cytokines and reactive oxygen species, which can exacerbate neurodegeneration. In diseases like Alzheimer's, neuroinflammation accelerates the accumulation of toxic proteins such as amyloid-beta and tau, worsening cognitive decline. Research shows that targeting inflammatory pathways may help slow or prevent neurodegeneration. Understanding the delicate balance between protective and destructive inflammation is key to developing new therapeutic strategies. Advances in neuroimaging and molecular biology are enhancing our ability to study these processes, offering hope for more effective treatments in the future.

Track 9: Neurodevelopmental Disorders

Neurodevelopmental disorders are a group of conditions that affect brain development, leading to challenges in areas such as learning, behavior, communication, and social interaction. These disorders typically emerge in early childhood and can include autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), intellectual disability, and learning disorders. Causes may involve genetic factors, prenatal exposures, or early environmental influences. Early diagnosis and intervention are critical for improving outcomes, often involving therapies like behavioral interventions, speech and occupational therapy, and educational support. Advances in neuroscience and genetics are helping to better understand the underlying mechanisms of these disorders, leading to more personalized treatment approaches. Supportive, inclusive environments are essential to help individuals with neurodevelopmental disorders reach their full potential and lead fulfilling lives.

Track 10: Computational Psychiatry

Computational psychiatry is an emerging field that applies mathematical modeling, neuroscience, and computer science to understand mental disorders. It aims to bridge the gap between brain function and psychiatric symptoms by analyzing complex data from brain imaging, behavior, genetics, and clinical observations. Using tools like machine learning and computational models, researchers can identify hidden patterns and predict individual responses to treatments. This approach helps in refining diagnoses, understanding the underlying mechanisms of disorders such as depression, schizophrenia, and anxiety, and developing more personalized and effective interventions. Unlike traditional psychiatry, which often relies on subjective assessments, computational psychiatry offers objective, data-driven insights into mental health. It also contributes to identifying biomarkers for early detection and risk assessment. Despite being a relatively new discipline, it holds great promise in transforming psychiatric care by making it more precise, predictive, and personalized, ultimately improving patient outcomes and advancing mental health research.

Track 11: Intelligent Neural Interfaces

Intelligent neural interfaces are advanced technologies that connect the brain or nervous system with external devices to monitor, interpret, or modulate neural activity. These interfaces combine neuroscience, engineering, and artificial intelligence (AI) to create systems that can adapt to and learn from neural signals in real time. Applications include brain-computer interfaces (BCIs) for communication in paralyzed individuals, neuroprosthetics for restoring movement, and devices for treating neurological disorders such as epilepsy or Parkinson’s disease through targeted stimulation. Intelligent neural interfaces are designed to be minimally invasive, energy-efficient, and capable of long-term operation. AI algorithms enhance their ability to decode complex brain activity and adjust responses dynamically, improving performance and user experience. Ongoing research focuses on improving biocompatibility, miniaturization, and wireless communication. These technologies represent a promising future for personalized neurotherapies, cognitive enhancement, and seamless integration between humans and machines, offering new hope for those with severe neurological impairments.

Track 12: Neurodegeneration & Aging Disorders

Neurodegeneration is the process of losing Neurons within the Brain and spinal cord. Neuron is build blocks for the nervous system including brain and spinal cord. Neurons cannot be regenerated or replace by body normally. Ageing affects many cellular processes that progress to the neurodegeneration and also age-related changes in cellular function will progress to the pathogenesis of PD. well known Neurodegenerative disease are Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS). Neurodegenerative diseases are genetically inherited causative genes for neurodegenerative disease has been identified by using recent advance in the genetics, Drug therapies were provided for Neurodegenerative disease by three treatment categories symptomatic, protective and curative.

Track 13: Pediatric Neurology

Pediatric neurology is a blend of both neurology and pediatrics. Pediatric neurology is a branch of medication primarily managing scatters of the nervous system. Pediatric neurology manages the determination and treatment of all maladies including the focal and fringe sensory system and its subdivisions, the autonomic sensory system and the physical sensory system, including their covers, veins and all effector tissues, for example, muscles. A medicinal expert who represents considerable authority in this field of pediatric neurology is called pediatric neurologists.

Track 14: Neuropharmacology

Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology one is behavioral and the other one is molecular. Behavioral neuropharmacology focuses on the study of how drugs affect human behavior (Neuropsychopharmacology), including the study of how drug dependence and addiction affect the human brain. Molecular neuropharmacology involves the study of neurons and their neurochemical interactions, with the overall goal of developing drugs that have beneficial effects on neurological function. Both of these fields are closely connected, since both are concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Studying these interactions, researchers are developing drugs to treat many different neurological disorders, including pain, neurodegenerative diseases.

Track 15: Neurogenesis and Brain Repair

Neurogenesis and brain repair are critical areas of neuroscience focused on the brain's ability to regenerate and recover after injury or disease. Neurogenesis, the process of generating new neurons, primarily occurs in the hippocampus—a region involved in learning and memory. In adults, this process is limited but can be influenced by factors such as exercise, enriched environments, and certain medications. Brain repair also involves neuroplasticity, where existing neurons form new connections to compensate for lost functions. These mechanisms are especially important in recovering from stroke, traumatic brain injury, or neurodegenerative diseases. Advances in stem cell therapy, gene editing, and biomaterials are being explored to enhance neurogenesis and support tissue regeneration. While significant challenges remain, such as ensuring proper integration and function of new cells, research in this field offers promising avenues for restoring cognitive and motor functions. Ultimately, promoting brain repair holds great potential for improving outcomes in neurological disorders.

Track 16: Mental Health

Mental health encompasses our emotional, psychological, and social well-being, crucial for how we think, feel, and act. It affects daily life, relationships, and productivity. Good mental health allows us to handle stress, make decisions, and cope with challenges. Mental illnesses, such as anxiety and depression, impact thoughts, feelings, and behaviors, requiring support and treatment. Awareness and destigmatization are vital to encourage seeking help when needed. Self-care practices, like exercise and mindfulness, promote mental well-being. Addressing mental health openly fosters resilience and a balanced life, highlighting its significance in overall health and quality of life.

Track 17: Addiction & Brain Disorders

Addiction is a disorder of brain (Brain Disorder) and its complex condition. Addiction is also known as chronic disorder which includes psychological, biological, environmental factors and social factor influenced by development and maintenance. Genetic might be the risk factor for addiction sometimes For example engaging in certain behaviors (such as gambling) and the way the body processes alcohol or other drugs. Addiction can be prevented, treated and managed by the healthcare professionals with the co-operation of family or peer support like social worker. Addiction directly affects the function of brain and body which will result in problems in families, relationship, friends, schools, workplaces and neighborhoods.

Track 18: Psychiatric Disorders and Neurobiology

Psychiatric disorders, such as depression, schizophrenia, and bipolar disorder, are increasingly understood through the lens of neurobiology. These conditions arise from complex interactions between genetics, brain chemistry, and environmental factors that affect brain structure and function. Neurobiological research focuses on abnormalities in neurotransmitter systems, neural circuits, and brain regions involved in mood, cognition, and behavior. For example, imbalances in serotonin and dopamine are linked to mood and psychotic disorders. Advances in brain imaging and molecular genetics have helped identify biomarkers for diagnosis and treatment response. Understanding the neurobiological basis of psychiatric disorders enables the development of targeted therapies, including medications and neuromodulation techniques like transcranial magnetic stimulation. This integrative approach aims to improve treatment outcomes and reduce stigma by framing psychiatric conditions as brain-based disorders, promoting better mental health care.

Track 19: Neurorehabilitation Techniques

Neurorehabilitation techniques are specialized therapies aimed at helping individuals recover or improve function after neurological injuries or disorders, such as stroke, traumatic brain injury, or spinal cord injury. These techniques focus on restoring motor skills, cognitive abilities, speech, and daily living activities. Common methods include physical therapy, occupational therapy, speech therapy, and cognitive rehabilitation. Advances in technology have introduced innovative approaches like virtual reality, robotic-assisted therapy, and brain-computer interfaces, which enhance engagement and effectiveness. Neurorehabilitation also leverages neuroplasticity, encouraging the brain to form new connections and compensate for damaged areas. Personalized treatment plans are essential, addressing each patient’s specific deficits and goals. Overall, neurorehabilitation techniques play a vital role in improving quality of life, promoting independence, and supporting long-term recovery for individuals with neurological conditions.

Track 20: Neuroplasticity Mechanisms

Neuroplasticity refers to the brain’s remarkable ability to reorganize and adapt by forming new neural connections throughout life. This process enables learning, memory, and recovery from injury. Neuroplasticity mechanisms include synaptic plasticity, where the strength of connections between neurons changes, and structural plasticity, involving the growth of new neurons and dendrites. Factors such as experience, environment, and injury can influence these changes. For example, after a stroke, neuroplasticity helps the brain reroute functions to undamaged areas. Therapeutic interventions like cognitive training, physical exercise, and brain stimulation aim to enhance neuroplasticity to improve recovery and cognitive function. Understanding these mechanisms is crucial for developing treatments for neurological disorders and brain injuries, highlighting the brain’s capacity for healing and adaptation across the lifespan.

Track 21: Neurodegenerative Diseases

Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of nerve cells (neurons) in the brain and nervous system. These diseases cause a decline in cognitive and motor functions, often leading to disability and loss of independence. Common neurodegenerative diseases include Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS). Each condition affects different parts of the nervous system and has distinct symptoms, such as memory loss, tremors, muscle weakness, and impaired coordination. The exact causes are not fully understood, but genetic, environmental, and lifestyle factors contribute to their development. While treatments exist to manage symptoms, there are currently no cures, and research continues to seek better therapies and prevention strategies.

Market Analysis

Brain disorders, including neurodegenerative diseases (such as Alzheimer's and Parkinson's), psychiatric conditions (like depression and schizophrenia), and neurological disorders (such as epilepsy and migraines), are among the most pressing global health concerns. With an aging population and rising awareness of mental health, the demand for effective treatments is driving substantial growth in the neurology medicine market.

The neurology medicine market is experiencing rapid expansion due to advancements in research, the introduction of novel therapies, and increasing healthcare investments. According to market reports, the global neurology drug market is expected to grow at a compound annual growth rate (CAGR) of over 8% in the coming years. Factors such as increasing cases of neurological disorders, the development of innovative biologics, and the rise of personalized medicine contribute significantly to this growth.

One of the key drivers of the market is the emergence of disease-modifying treatments, especially in conditions like Alzheimer's and multiple sclerosis. The adoption of precision medicine and gene therapies is also opening new doors for effective interventions. Additionally, the growing use of artificial intelligence and digital health technologies in neurology is transforming diagnosis and treatment approaches.

Despite the promising growth, challenges such as high drug development costs, complex regulatory approvals, and limited treatment options for some neurological disorders remain barriers to market expansion. However, increasing collaborations between pharmaceutical companies, biotech firms, and research institutions are expected to accelerate drug discovery and innovation.

As the prevalence of brain disorders rises globally, the neurology medicine market is poised for significant growth, offering new hope for millions of patients. Investments in research and development will be crucial in shaping the future of neurological treatments and improving patient outcomes.

Accreditation

All major Conference Series Conferences are accredited with Continuing Education (CE), Continuing Professional Development (CPD) and Continuing Medical Education (CME) credits respectively.

CME Credits:

Continuing Medical Education (CME) refers to a specific form of continuing education that helps medical professionals to maintain competence and learn about new and developing areas of their field. Conference Series Conferences are recognised and accredited with CME credits to enhance the professional abilities and skills of participants. CME credits are important to physicians because they require a specified number of credits annually to maintain medical licenses. CME credits are authorized by the Accreditation Council for Continuing Medical Education. Attending CME accredited conference is beneficial and valuable to physicians and other medical professional as it is a source of constant improvement that ultimately improves their medical practice, and keeps them up-to-date on the latest technologies, advancements, treatments, etc. Speaking at CME activities can also be a great stage for clinical medical professionals to share their expertise and increase their distinction in their specialty.

CE Credits:

Continuing Education (CE) credit is a measure used in continuing education programs to assist the professional to maintain his or her license in their profession. Conference Series Conferences provides ample opportunities to acquire CE credits. CE can open up previously closed doors and lead to better job opportunities. CE usually refers to college courses or other vocational training obtained by older adults or working professionals. CE credits work as carrier promoter and hold great value in medical, clinical and other areas of research even after completion of degrees in concerned field of research. It is pivotal in today’s world to get updated information on your field of research and profession. Attending Continuing Education Conferences can help expand your network and make connections that could translate into profitable relationships or job opportunities down the line. It also plays a vital role in recruiting new team members for an employer with open positions. CE helps licensing organizations and professional membership groups. Continuing Education promotes high quality performance, keep professionals up to date with the latest advances, and provide excellent networking opportunities.

CPD Credits:

Continuing Professional Development (CPD) is the holistic commitment of professionals towards the enhancement of personal skills and proficiency throughout their careers. It enables learning to become conscious and proactive, rather than passive and reactive. CPD accreditation is important because it ensures that courses provided adhere to the highest educational standards and international benchmarks of quality and learning. CPD enriches your knowledge, keeps you currently competent and is the key to career progression and professional growth. There are many advantages to carrying out CPD that includes filling gaps in your knowledge and skills to become more productive and efficient, building confidence and credibility to stand out from the crowd, achieving your career goals and demonstrating professional status. CPD hours can be earned through continuing education, leadership activities, instructional activities, completion of significant work projects, research and publications. Conference Series Conferences have been accredited with CPD credits to expedite the progress of research and industry professionals.

Past Conference Report

Brain Disorders 2024

We had a huge success with the completion of 13^th International Conference on Brain Disorders and Therapeutics which was held in December 12-13, 2024 in Rome, Italy. The significance of the meeting was achieved due to the accumulation of all the related group of spectators of research scientists to share their Knowledge, Research work, Technologies, and furthermore trade of worldwide Information towards the correct crowd at ideal time. Congress has received a generous response from all over the world. This has been organized with the aim of endorsing the development of new perceptions and ideas for investigating the high level of knowledge reached by scientific community in the field of brain disorders and neurology.

The conference was organized around the theme “Intersection of Mental Health and Neurology”. The congress entrenched a firm relation of future strategies in the field of brain disorders and neurology, We would like to thank each and every participant of Brain Disorders 2024 to make this a huge success. And special thanks to media partners for the promotion of our event, The Conferences aim to bring together the prominent researchers’ academic scientists, and research scholars to exchange and share their experiences on all aspects of brain disorders and neurology. It is conjointly a knowledge domain platform for researchers, practitioners and educators to gift and discuss the foremost recent advances, trends, and issues in addition as sensible challenges and solutions adopted in the fields of brain disorders and neurology, We are glad to announce its “14^th International Conference on Brain Disorders and Therapeutics", going to be held during October 06-07, 2025 in Las Vegas, USA. We cordially welcome all the eminent Researchers, Scientists and Professors to be part of this prestigious conference, Bookmark your dates for “Brain Disorders 2025” as the Nominations for Best Poster Awards and Young Researcher Awards are open across the world.